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1 TRANSPLANTATION OF HUMAN
MONOCYTE-DERIVED ‘NEO-HEPATOCYTES’
INTO RODENT ANIMAL MODELS—ANALYSIS
OF INTEGRATION AND IN VIVO FUNCTION
Ruhnke M2, Hengstler J1, Dietl H2, Lange H2, Ungefroren H2,
Nussler A3, Kremer B2, Faendrich F2, (1) Institute of Toxicology,
University of Leipzig, Leipzig, Germany; (2) Department of General
and Thoracic Surgery, University of Schleswig-Holstein, Campus
Kiel, Kiel, Germany; (3) Fresenius Biotech AG, Bad Homburg,
Germany
INTRODUCTION AND AIM: Liver transplantation is the only
curative treatment of end-stage liver diseases. There is a great
demand for alternatives such as biomedical bridging devices or
hepatocyte transplantation. We have generated “neo-hepatocytes”
from human monocytes which show specific in vitro functions and
transplanted these “neo-hepatocytes” into livers of healthy mice and
into the spleens of non-albuminergic Nagase rats. PATIENTS AND
METHODS: Human monocytes were exposed to MCSF and IL-3
for 6 days, then to FGF4 for 10 days. After confirmation of albumin
secretion 1r107 cells were injected intrahepatically into immuno-
competent healthy mice or into the spleen of immunosupressed
Nagase rats. Liver and spleen specimens were analyzed for human
albumin expression at days 5, 10 and 21 after transplantation. Fusion
was analyzed by in situ hybridization. In Nagase rats levels of human
albumin were measured in the serum at days 3, 7, 10 and 21.
RESULTS: In mice “neo-hepatocytes” integrated into the liver
parenchyma and could be visualized up to day 21. They specifically
express human albumin, not mouse albumin and form small colo-
nies. There were no signs of rejection. Fusion was excluded by FISH.
In Nagase rats serum levels of human albumin increased rapidly
after injection of “neo-hepatocytes” following a decrease after day
10. Cells integrated into the spleen and liver of Nagase rats.
CONCLUSION: “Neo-hepatocytes” integrate into liver paren-
chyma of rodents and show reliable albumin synthesis in vivo. If
produced from a human individual these cells could serve for auto-
logous treatment of liver disease without the need for immunosup-
pressants.
2 TAURINE IMPROVES HEPATIC MICROCIRCULATION
AFTER WARM ISCHEMIA IN THE RAT
Kincius M1, Ryschisch E1, Riu L1, Flechtenmacher C2, Mehrabi A1,
Gebhard MM2, Kraus TW1, Bu¨chler MW1, Schemmer P1,
(1) Department of Surgery; (2) Department of Pathology; (3)
Department of Experimental Surgery, Ruprecht-Karls-University,
Heidelberg, Germany
INTRODUCTION AND AIM: Reperfusion injury is characterized
by both activated Kupffer cells and disturbed hepatic microper-
fusion. As taurine, a conditionally essential amino acid, potentially
prevents activation of Kupffer cells in vitro, this study was designed to
investigate its effect on both liver injury and intrahepatic micro-
circulation after warm ischemia. PATIENTS AND METHODS:
Female Sprague Dawley rats (170–210 g) were divided into three
groups. In sham controls only laparotomy was performed. Some
animals were given taurine (10 mg/kg i.v.; 1.2 ml) 10 min prior to
ischemia. Ringer’s solution (1.2 ml) was given to controls. In both
study groups the left liver lobe underwent 60 min of warm ischemia.
Subsequently, both transaminases and histology were assessed to
indicate liver injury. In vivo microscopy (IVM) was performed to
evaluate interaction between leukocytes and endothelial lining cells.
To determine whether taurine prevents activation of Kupffer cells,
latex beads taken up by Kupffer cells were counted and the serum
level of TNF-alpha was compared to controls. Further, ICAM-1
expression was shown with immunohistochemistry. For comparison
between study groups ANOVA test was used as appropriate. Results
are presented as mean+SEM. RESULTS: Taurine given before
warm ischemia significantly decreased both ALT and AST from
278+74 U/l and 392+22 U/l in controls to 129+19 U/l and 268+
26 U/l, respectively 8 h after reperfusion. Histological changes, i.e.
neutrophil infiltration, necrotic cell death and ICAM-1 expression,
were markedly reduced by 14% to 34% after taurine (p50.05) at 8 h
after reperfusion. Further, taurine dramatically improved micro-
circulation. The number of stickers was reduced to 76% of controls
in sinusoids and to 53% of controls in venules (p50.05) while rolling
was decreased to 37% in venules (p50.05). Taurine significantly
decreased both phagocytic activity of Kupffer cells and TNF-alpha
release (p50.05). CONCLUSION: This study demonstrates that
taurine decreases liver injury after warm ischemia, most likely via
Kupffer cell-dependent mechanisms including leukocyte–endo-
thelial cell interaction upon reperfusion.
3 EXTENT OF HEPATIC RESECTION IN CAROLI
DISEASE: A MULTI-INSTITUTIONAL RETROSPECTIVE
STUDY OF 26 PATIENTS
Mabrut JY1, Baulieux J1, Boillot O2, Gigot JF4, Lerut J5, Otte JB6, De
Ville de Goyet J6, Partensky C3, (1) Digestive Surgery and Liver
Transplant Unit, Croix-Rousse Hospital, Lyon, France; (2) Liver
Transplant Unit, Edouard Herriot Hospital, Lyon, France;
(3) Hepato-Biliary and Liver Unit, Edouard Herriot Hospital, Lyon,
France; (4) Hepato-Biliary and Liver Unit, Saint Luc Hospital,
Bruxelles, Belgium; (5) Liver Transplant Unit, Saint Luc Hospital,
Bruxelles, Belgium; (6) Pediatric and Liver Transplant Unit,
Saint Luc Hospital, Bruxelles, Belgium
INTRODUCTION AND AIM: To report the results of a retro-
spective multi-institutional study of 26 patients suffering from Caroli
disease. PATIENTS AND METHODS: The mean age was 51 years
(range 11–76 years). Twenty-one patients were symptomatic at
time of diagnosis; Intrahepatic bile duct stones, congenital hepatic
fibrosis (CHF) and cholangiocarcinoma were associated in 13
patients, 4 patients and 1 patient, respectively. All patients, except
one suffering from a unilobar disease with CHF, were operated on
with liver resection tailored to the extent within the liver: for bilobar
disease (2 liver transplantations for associated CHF, 2 left extended
hepatectomy, 1 trisegmentectomy 4 to 6), for left unilobar disease
(8 left lateral segmentectomies, 7 left hepatectomies) and right
unilobar disease (3 right hepatectomies, 1 bisegmentectomy 5–6,
1 liver transplantation for associated CHF). RESULTS: Post-
operative mortality and morbidity at 2 months occurred in 0 and
13 patients, respectively. Two patients presented with synchronous
cholangiocarcinoma. During a mean follow-up of 94 months in 21
patients with a follow-up time exceeding 6 months, 4 patients
developed recurrent complicated intrahepatic stones. Another
elderly patient developed biliary cirrhosis. Patients are alive and
disease-free in 11/13 of left unilobar forms, in 4/4 of right unilobar
forms and in 1/3 of bilobar forms of the disease. CONCLUSION:
Unilobar forms of Caroli’s disease are successfully treated by radical
hepatic resection. For bilobar forms, the therapeutic management
is more difficult and liver transplantation could be mandatory,
especially in case of CHF.
4 ADVANCED HEPATIC TISSUE DESTRUCTION
IN ABLATIVE CRYOSURGERY: POTENTIALS OF
INTERMITTENT FREEZING AND SELECTIVE
VASCULAR INFLOW OCCLUSION
Richter S1, Kollmar O1, Menger MD2, Schilling MK1, Pistorius
GA1, (1) Department of General, Visceral, Vascular and Pediatric
Surgery; (2) Institute for Clinical & Experimental Surgery,
University of Saarland, Homburg, Germany
INTRODUCTION AND AIM: Recent studies indicate that cryo-
surgery represents a promising approach to treat non-resectable liver
tumours. To improve parenchymal tissue destruction, a variety of
modifications of the freeze-thaw procedure have been suggested,
including repetitive freezing and portal-triad cross-clamping. The
aim of the present study was to analyse whether intermittent freezing
by application of a double freeze-thaw procedure or selective vascular
inflow occlusion are more effective than a single freeze-thaw cycle
to achieve complete hepatic tissue destruction. PATIENTS AND
METHODS: Using a porcine model, intrahepatic cryolesions were
induced by freezing the hepatic tissue for a total of 15 min (n=6,
SF). Additional animals (n=6) underwent a double freeze-thaw
cycle of 7.5 min each (DF). A third group of animals (n=6) was
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treated by a single 15-min freeze-thaw cycle during selective vascular
inflow occlusion (VO-SF). RESULTS: 7 days after freezing, DF did
not change the volume of the cryolesion (25.4+1.7 cm3) compared
to SF (29.9+3.7 cm3), however, resulted in enhanced destruction of
hepatocyte nuclear morphology (DF-score: 2.4+b0.2 vs SF-score:
1.1+0.3; p50.05) and attenuated leukocyte infiltration within the
margin of the cryolesion (DF-score: 1.5+0.2 vs SF-score: 2.8+0.1;
p50.05). VO-SF was also effective to significantly enhance destruc-
tion of hepatocyte nuclear morphology (2.8+0.1; p50.05 vs SF),
but, additionally, markedly increased the volume of the cryolesions
(43.3+5.3 cm3; p50.05 vs SF and DF). Interestingly, VO-SF
further increased the number of apoptotic cells, while leukocyte
infiltration (2.3+0.3) was not affected compared to that after SF
treatment. CONCLUSION: Thus, our data indicate that both DF
and VO-SF are effective to enhance parenchymal cell destruction
within the margin of the cryolesion. VO-SF additionally increases
the volume of the lesion, and may therefore be most attractive for
successful clinical application.
5 EARLY AND LATE LOCAL RECURRENCE FOLLOWING
RFA IN NON-RESECTABLE LIVER CANCER: DIAGNOSIS
AND TREATMENT
Eisele RM1, Schumacher G1, Spinelli A2, Neuhaus P1,
(1) General, Visceral & Transplantation Surgery,
Charite´ Virchow Clinic, Berlin, Germany; (2) General
Surgery, Istituto Clinico Humanitas, Italy
INTRODUCTION AND AIM: Radiofrequency ablation (RFA)
provides excellent results in small liver tumors which are not
resectable. So far, no standardized protocols are available for recur-
rent disease. This retrospective study describes strategies for follow-
up and further treatment. PATIENTS AND METHODS: 91 RFA
treatments in 61 patients were analyzed. RFA was only considered in
non-resectable liver cancer. Postoperative screening included sono-
graphic examinations at intervals of 3, 6 and 12 months post-
operatively and further annual follow-up examinations. Mean follow-
up period was 11.8 months. Whenever possible, further surgical or
interventional treatment was offered in case of local tumor recurrence
(LTR). RESULTS: Overall local recurrence rate was 14% (13
patients); 9 of them (69%) were detected within the first 9 months
after RFA, whereas 3 (23%) occurred later than 12 months after
RFA. LTR could be observed up to 16 months following the
procedure. In 9 patients (69%), further treatment was done: 6
patients (75%, 52% of all patients with LTR) underwent RFA again,
one patient could be treated by LITT, and 2 patients (22%, 15%
of all patients with LTR) recovered from hepatic dysfunction so
that surgical resection was possible. CONCLUSION: Distribution
of LTR in the post procedure time course suggests a rather strict
examination schedule with time points every 3 months within the first
year and an additional time point after 18 months following RFA.
About half of all patients with LTR can be subjected to secondary
RFA; however, liver resection is not excluded even in case of LTR.
6 INTER-ORGAN AMINO ACID EXCHANGE ACROSS
THE INTESTINES AND THE LIVER IN SURGICAL
PATIENTS WITH A NORMAL LIVER
van de Poll MCG3, Siroen M1, Beets-Tan R2, Affourtit J2, Melis G1,
van Leeuwen P1, Deutz N3, Soeters P3, Dejong C3, (1) Surgery, VU
University Medical Center; (2) Radiology, Maastricht University;
(3) Surgery, Maastricht University, Maastricht, The Netherlands
INTRODUCTION AND AIM: Due to difficult accessibility of the
portal vein, human data on hepatic and intestinal amino acid meta-
bolism are limited. Data concerning the healthy liver are completely
lacking. We aimed at investigating inter-organ amino acid exchange
across the normal human liver. PATIENTS AND METHODS: In
10 patients without parenchymal liver disease undergoing surgery,
blood was sampled simultaneously from an indwelling arterial line,
hepatic vein and the portal vein. Amino acid and ammonia concen-
trations were measured to calculate arteriovenous differences (V-A).
Portal and hepatic arterial blood flow was measured using duplex to
quantify metabolic flux ((V-A)rblood flow). RESULTS: Intestines:
There was significant intestinal uptake of glutamine and glutamate:
(mean (SEM) 41.5 (6.9) and 5.1 (1.6) mmol/kg/h respectively
(p50.05)) and release of alanine, citrulline and ammonia: 17.3 (3.6),
5.1 (1.0) and 38.7 (10.4) mmol/kg/h, respectively (p50.005). There
was no significant flux of essential amino acids and therefore no net
protein breakdown in the gut. We found a stoichiometric correlation
between intestinal glutamine uptake and ammonia release (r2=0.50,
p=0.023). Liver: Hepatic ammonia uptake (40.9 (12.3) mmol/kg/h)
was directly related to intestinal ammonia production (r2=0.94,
p50.001) making total splanchnic ammonia release insignificant.
Hepatic uptake of branched-chain amino acids (9.4 (2.8) mmol/kg/h,
p=0.01) reflects net hepatic protein synthesis in the postabsorptive
state. CONCLUSION: This is the first report of amino acid and
nitrogenexchangeacross thenormalhuman liver. In these subjects the
liver serves as an ammonia trap, metabolizing all intestinal-derived
ammonia, making splanchnic ammonia release insignificant. The
described methods will be implemented in forthcoming experiments.
7 COMPARISON OF HISTOLOGICAL AND MRI
APPEARANCES OF LIVER ABLATION USING
ELECTROLYSIS RADIOFREQUENCY THERAPY NEAR
LARGE HEPATIC VEINS
Metcalfe MS1, Mullin E1, Maddern G2, Berry DP1, Dennison A1,
(1) Hepatobiliary Surgery, Leicester General Hospital, Leicester,
UK; (2) Hepatobiliary Surgery, Adelaide University, Adelaide,
Australia
INTRODUCTION AND AIM: Hepatic ablation by radiofrequency
(RF) or electrolysis may be less effective adjacent to large veins due to
heat or current sink. The correlation of magnetic resonance imaging
(MRI) appearances after ablation with tissue necrosis is not known.
The aims of this study were to correlate MRI and histological findings
after RF and electrolytic hepatic ablation adjacent to large hepatic
veins. PATIENTS AND METHODS: Two central hepatic veins
were identified in each of 10 large white pigs at laparotomy by
ultrasound. Adjacent to one an electrolytic lesion was centred, and a
radiofrequency lesion adjacent to the other. The livers were harvested
72 h later. MRI and histological examination were performed to
determine volume of lesions produced and extent of necrosis.
RESULTS: For technical reasons it was possible to perform RF in
only 8 animals. On MRI, 9 of 10 electrolytic lesions and 5 of 8 RF
lesions were seen to completely encase a hepatic vein with the
remainder just touching the vessel. On histology all electrolytic
lesions produced necrosis up to the vessel wall and only one radio-
frequency lesion did not show necrosis up to the wall of the adjacent
vein. The lesion volumes on histology and MRI correlated well.
However, the necrosis was not complete adjacent to the vessel wall
for any lesion. CONCLUSION: MRI accurately predicts the volume
of necrosis produced by hepatic ablation. However, incomplete
necrosis in lesions raises concerns for the efficacy of ablation of
malignant lesions adjacent to large veins.
8 CCl4-INDUCED ACUTE LIVER FAILURE WITH
PORTAL VEIN ARTERIALIZATION IN THE RAT
Nardo B1, Puviani L1, Bertelli R1, Beltempo P1, Cavallari G1,
Montalti R1, Pacile` V1, Licursi M1, Caraceni P2, Pertosa AM2,
Pariali M3, Cavallari A1, (1) Department of Surgery and
Transplantations; (2) Department of Internal Medicine,
Cardioangiology and Hepatology; (3) Biomedical Research Center,
S. Orsola Hospital, Bologna, Italy
INTRODUCTION AND AIM: Liver transplantation remains the
most effective therapy for acute liver failure (ALF). However, we
aimed to determine whether the increase of oxygen supply to the liver
by portal vein arterialization (PVA) is an effective treatment for ALF.
PATIENTS AND METHODS: ALF was induced in rats by CCl4
solution i.p. Twenty-four hours later, the rats were divided: (1)
Control-group: no treatment; (2) PVA-group: an arterial-portal
shunt was performed by connecting left renal artery to splenic vein
with a polyethylene stent following nephrectomy and splenectomy.
The rats were sacrificed after 1, 2 and 10 days to collect serum and
liver samples. A separate group was used to assess 10-day survival.
RESULTS: CCl4-induced liver injury was greatly reduced in the
PVA group compared with control rats as indicated by the signifi-
cantly lower serum transaminases levels and degree of liver necrosis
at histology. In contrast, rats treated with PVA showed a progressive
and rapid improvement of liver tissue injury with a score of 2.7, 1.5
and 0.2 at 1, 2 and 10 days, respectively. Contrary to control rats,
hepatocyte regeneration was observed already at 24 h in the peri-
portal area and it diffused to the entire lobule at 48 h in the PVA
group. Accordingly, PVA significantly improved survival after
CCl4 administration compared to control group (100 vs 33%).
CONCLUSION: The supply of oxygen to the portal system
promotes hepatocyte regeneration leading to resolution of massive
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necrosis in a toxic model. Thus PVA may represent a novel approach
for treatment of acute liver failure.
9 RADIOFREQUENCY ABLATION OF LIVER
TUMOURS: A SAFE AND EFFECTIVE FORM OF THERAPY
Bhattacharya S, Fotheringham T, McGhie J, Krissat J, Hutchins R,
Departments of Surgery and Radiology, Royal London Hospital,
London, UK
INTRODUCTION AND AIM: To assess the efficacy and safety
of radiofrequency ablation (RFA) of liver tumours as a therapeutic
measure. PATIENTS AND METHODS: RFA was performed
either percutaneously, under general anaesthesia or intravenous
sedation, with ultrasound or CT to localize the lesions, or at open
surgery as an adjunct to resection. The RFA kit used was manu-
factured by Boston Scientific, and standard technique was adopted.
A follow-up CT scan was performed at 6–8 weeks. The decision to
perform RFA as opposed to other therapies was made on the basis of
age, performance status, tumour number/location, previous treat-
ments, patient choice, tumour behaviour and prognosis, or irresect-
ability found at laparotomy. All patients were treated by the same
surgical team and the same radiologist. RESULTS: From 2001 to
2004 (40 months), 89 tumours in 32 patients were ablated at 40
sessions of RFA. Eight patients had primary hepatocellular carci-
noma (HCC), 21 had metastatic colorectal cancer (CRC), 3 had
other metastatic lesions. Of the 40 sessions, 26 involved percuta-
neous RFA, 8 involved RFA at laparotomy, and 6 involved RFA in
conjunction with a liver resection. Five patients underwent more
than 1 session of RFA, either to treat multiple lesions which could
not all be treated at one session, or to treat metachronous recurrence.
Tumour diameters ranged from 1 to 5 cm (mean 3.2 cm). Compli-
cations included significant pyrexia (n=1), and a skin burn around
the needle (n=1). One patient with HCC, cirrhosis and aortic
stenosis died of bile leak, sepsis and respiratory failure 5 days after
RFA of 4 lesions under general anaesthesia. In 31 of the 40 sessions,
follow-up CT indicated a satisfactory burn. Of 8 patients with HCC,
3 received further chemoembolisation, and 1 received a transplant.
Of 21 patients with CRC, 8 received further chemotherapy. Overall,
22 patients developed recurrent disease. Follow-up has ranged from
2 to 40 months, and 17 of 32 patients are alive. CONCLUSION:
RFA is a safe and effective form of therapy for liver tumours, and
needs to be used judiciously as part of a multi-disciplinary approach.
10 NOVEL PROCEDURE: PERCUTANEOUS, VIA TIPS,
PORTAL VEIN THROMBECTOMY IN PATIENTS WITH
BUDD-CHIARI SYNDROME COMPLICATED BY ACUTE
PORTAL VEIN THROMBOSIS
Ben-Haim M5, Samuels D1, Nakache R2, Oren R3, Kessler A4,
Kori I1, (1) Invasive Radiology; (2) Transplantation; (3) Hepatology;
(4) Sonography; (5) Liver Surgery, Tel-Aviv Sourasky Medical
Center, Tel-Aviv, Israel
INTRODUCTION AND AIM: Acute portal vein thrombosis (PVT)
is a devastating complication of Budd-Chiari syndrome and hyper-
coagulability. Conservative approach, anticoagulation, systemic or
transarterial (SMA) thrombolysis and even urgent liver transplanta-
tion have been applied in this scenario, but with poor results. We
describe a novel approach to treat acute PVT. PATIENTS AND
METHODS: Clinical diagnosis was confirmed with US Doppler.
Initial treatment was supportive. Right portal vein localization was
achieved by transarterial portogram or by CT-guided microcoil
placement. Trans-jugular intrahepatic porto-systemic shunt (TIPS)
was performed and included three Wallstents# and a Jograft# in one
case and a Viatorr# stentgraft that was extended later with a
Hemobahn# stentgraft in another. Mechanical clot removal from
the portal system was performed in the primary procedure and in a
revision procedure in the following few days. Stents were placed
precisely with no extension into the IVC or deeply into the main
portal vein. Patients were fully anticoagulated and patency was as-
sessed by US Doppler tests. RESULTS: Two young female patients
were treated accordingly. Clinical presentation included acute liver
failure, followed by rapidly progressive tense ascites, renal and
respiratory failure. The procedures were performed on days 5 and 10
following admission. In both cases, successful thrombectomies were
achieved and maintained. In one patient, partial occlusion of the
TIPS and re-accumulation of ascites were conquered with repeated
procedure. Both patients were discharged without ascites and with
normal liver function. CONCLUSION: Urgent TIPS and TIPS via
portal vein thrombectomy is a novel procedure which offers a safe and
effective treatment for patients with acute portal vein thrombosis.
11 LOCAL PREDISPOSING FACTORS FOR FRANK
INTRABILIARY RUPTURE OF HEPATIC HYDATID CYSTS
Ammori BJ1, l-Bahrani A1, Al-Maiyah M2, Finn P3, Al-Bahrani Z4,
(1) Department of Surgery, Manchester Royal Infirmary,
Manchester, UK; (2) Department of Surgery, Middlesbrough
General Hospital, Middlesbrough, UK; (3) Medical Statistics
Department, University of Teesside, Teesside, UK; (4) Department
of Surgery, Medical City Teaching Hospital, Baghdad, Iraq
INTRODUCTION AND AIM: Frank intrabiliary rupture (FIBR)
of hepatic hydatid cysts (HHC) is a common and serious complica-
tion, which occurs in 3–17% of cases. The aim of this study was to
detect local factors that carry a significant association with FIBR
of HHC and development of biliary cystic fistula (BCF). PATIENTS
AND METHODS: This was a retrospective and prospective study of
741 patients with HHC operated upon during 1965–2000. The
number, diameter, site, content and infection rate of the HHC were
reviewed and correlated to FIBR, which was statistically analysed.
RESULTS: Some 104 of 741 patients (14%) with a mean age of 42.9
years had FIBR with sizable BCF ranging between 3 and 8 mm
(mean 4.2 mm). The incidence of FIBR occurred at significantly
higher rates in patients with solitary rather than multiple cysts (18.5%
vs 5.8%, p50.001), cyst diameter 410 cm compared with smaller
cysts (45.8% vs 3.8%, p50.001), left hepatic lobar compared with
right lobar cysts (31.7% vs 12%, p50.001), multivesicular compared
with univesicular cysts (27.1% vs 2.8%, p50.001), and infected
compared with sterile cyst (34.3% vs 4.6%, p50.001). Multivariate
analysis confirmed that all the above variables (with the exception
of multiplicity of cysts) were independent predictors of FIBR.
CONCLUSION: This study draws attention to the endogenous local
risk factors for FIBR of HHC, which includes solitary, large, multi-
vesicular, infected and left lobar cysts. Patients at high risk of FIBR
should be offered early surgery.
12 MANAGEMENT OF HEPATOBILIARY CYSTS
Ali M, Department of Hepatobiliary Pancreatic Surgery,
Birdem, Dhaka, Bangladesh
INTRODUCTION AND AIM: Hepatobiliary cysts consist of a
heterogeneous group of diseases that differ in cause, prevalence and
manifestations. Symptomatic cysts and those that endanger life need
adequate treatment. The aim of the study was the evaluation and
approaches to management of various types of heptobiliary cysts in
a Hepato-Biliary-Pancreatic Surgery unit of a tertiary care hospital
in Bangladesh. PATIENTS AND METHODS: We treated 145
patients with hepatobiliary cysts between October 1996 and July
2004. There were 5 children and 140 adults. The most common was
simple cyst followed by hydatid and choledochal cysts. 54 (37.24%)
cysts were asymptomatic and diagnosed incidentally. 75 (51.72%)
had some form of symptoms. Complications like obstructive jaun-
dice, portal hypertension, venacaval obstruction, bronchobiliary
fistula and peritonitis were noted in the symptomatic patients.
Extrahepatic cystic and intrahepatic non-cystic lesions might simu-
late the features of hepatobiliary cysts, producing a diagnostic
dilemma. These cysts were treated by partial pericystectomy with
omentoplasty (44.83%), excision of the cyst with Roux-en-Y hepa-
ticojejunostomy (16.55%), partial pericystectomy with closure of the
biliary leakage and omentoplasty (13.8%), closed total cystectomy
(5.52%), right or left typical or atypical hepatectomy (14.49%),
sequential deroofing and fenestration (4.8%). Histological confir-
mation was made for all the cysts. RESULTS: There were no
perioperative mortality or major postoperative complications.
Recurrence was documented in 7 (4.83%) patients in 93 months of
follow-up. CONCLUSION: Hepatobiliary cysts demand a wide
spectrum of surgical strategies. Adequate intervention can offer cure
in most patients.
13 ADEQUATE SYMPTOM RELIEF JUSTIFIES
HEPATIC RESECTION FOR BENIGN DISEASE
Fioole B, Kokke M, van Hillegersberg R, Borel Rinkes IHM,
Surgery, University Medical Centre Utrecht, Utrecht,
The Netherlands
INTRODUCTION AND AIM: The purpose of this study was to
evaluate the long-term results of partial liver resection for benign liver
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lesions. PATIENTS AND METHODS: All patients operated on for
benign liver lesions from 1991 to 2002 were included. Information
was retrieved from medical records, the ZIS registration system and
by a telephone questionnaire. RESULTS: Thirty-five patients with a
median age of 41 years (17–71) were operated on (M/F ratio 6/29).
The diagnosis was hemangioma in 8 patients, FNH in 6, HCA in 13,
hydatid cyst in 3, and other diagnoses in 5. Ten patients were known
to have relevant co-morbidity. Median operating time was 215 min
(25–360). The morbidity and mortality rates were 31% and 2.9%,
respectively. Twenty-nine patients (83%) had symptoms (mainly
abdominal pain) prior to surgery. Twenty-eight patients were
reached for a questionnaire. The median follow-up was 52 months
(4–150). In 91% of patients preoperative symptoms had decreased or
disappeared after surgery. Four patients developed late complica-
tions. CONCLUSION: Long-term follow-up after liver surgery for
benign liver lesions shows considerable symptom relief and patient
satisfaction. In addition to a correct indication these results justify
major surgery with associated morbidity and mortality.
14 HEPATIC ATROPHY-HYPERTROPHY COMPLEX
DUE TO ECHINOCOCCUS GRANULOSUS
Karabulut K1, Ozden I1, Poyanli A2, Bilge O1, Tekant Y1, Acarli K1,
Alper A1, Emre A1, Ariogul O1, (1) General Surgery; (2) Radiology,
Istanbul University Istanbul Faculty of Medicine, Fatih—Istanbul,
Turkey
INTRODUCTION AND AIM: Obstruction of a major hepatic vein
or major portal vein or the biliary tree branch causes atrophy of the
related hepatic region and, frequently, hypertrophy in the remaining
liver—the atrophy-hypertrophy complex (AHC). Whether hydatid
cysts can cause AHC is controversial. PATIENTS AND METH-
ODS: The records of the 370 patients who underwent surgery for
hepatic hydatid disease between August 1993 and July 2002 (inclu-
sive) were evaluated retrospectively. RESULTS: Excluding 6
patients with previous interventions on the liver, AHC had been
recorded in the operative notes of 16 patients (4.4%); a cyst located in
the right lobe had caused atrophy of the right lobe and compensatory
hypertrophy of the left lobe. The CT images of 7 patients were
suitable for volumetric analysis. The median (range) right and left
lobe volumes were 334 (0–686) ml and 1084 (663–1339) ml,
respectively. The median (range) cyst volume was 392 (70–1363) ml.
CONCLUSION: AHC due to E. granulosus was confirmed by
objective volumetric analysis. The presence of AHC should alert the
surgeon to two implications. First, pericystectomy may be hazardous
due to association with major vasculobiliary structures. Second, in
patients with AHC, the hepatoduodenal ligament rotates around its
axis; this should be considered in order to avoid vascular injury if a
common bile duct exploration is to be performed.
15 MINIMALLY INVASIVE THERAPY OF INOPERABLE
HEPATOCELLULAR CARCINOMA (HCC) AND LIVER
METASTASES: A COMBINATION TREATMENT OF
CHEMOEMBOLIZATION AND RADIOFREQUENCY
THERMAL ABLATION (RFA)
Pomoni M1, Thanos L1, Mylona S1, Tsanis A1, Ellinas P1,
Karaliotas K2, Batakis N1, (1) Radiology; (2) Surgical,
Red Cross Hospital, Athens, Greece
INTRODUCTION AND AIM: To present an interventional ther-
apeutic protocol of inoperable primary HCC or liver metastases,
including RF and chemoembolization according to each lesion’s
characteristics. PATIENTS AND METHODS: In a period of 3
years, we treated 51 patients with HCC or liver metastases from a
distal organ. The selection of method was according to the following
criteria: unifocal HCC 56 cm in diameter—RF; unifocal HCC
46 cm in diameter—chemoembolization and, in selected cases, RF;
multifocal HCC—chemoembolization of the large lesions and RF of
the smaller lesions; liver metastases 55 cm in diameter—RF; liver
metastases 45 cm (especially hypervascular)—chemoembolization.
RESULTS: All lesions (100%) had good response in procedures,
presenting total or segmental necrosis at the 6-month follow-up with
dual-phase spiral CT. 85% of the treated lesions were stable or
smaller in size. We had no major complications (except right upper
quadrant pain after liver chemoembolization or mild pain at the
region of puncture when RF was performed, which was treated by
analgesics). CONCLUSION: Percutaneous treatment of inoperable
primary and metastatic liver diseases by using chemoembolization
and radiofrequency thermal ablation is a safe highly effective method
which provides a better quality of life for patients.
16 EVALUATION OF A NOVEL REUSABLE BIPOLAR
VESSEL SEALING DEVICE: EVIDENCE FOR A
DIFFERENTIAL ARTERIAL AND VENOUS INFLAMMATORY
RESPONSE
Richter S1, Kollmar O1, Schilling MK1, Menger MD2, Pistorius
GA1, (1) Department of General, Visceral, Vascular and Pediatric
Surgery, University Hospital of Saarland; (2) Institute for Clinical &
Experimental Surgery, Homburg, Germany
INTRODUCTION AND AIM: During the last few years a variety
of energy-based techniques for arterial and venous vessel ligation
have been introduced. With the use of a porcine model we herein
compared the efficacy of the novel reusable BiClamp versus the
standard disposable LigaSure bipolar vessel sealing device. We
studied whether arteries respond differently to veins upon sealing.
PATIENTS AND METHODS: Splenectomy and nephrectomy
were performed in five Suabian Hall pigs with the use of the two
different bipolar vessel sealing devices. Measurements of the sealed
arteries and veins (diameters 2–7 mm) included rate of seal failure,
burst strength and heat-associated vascular wall morphology
appearance. An additional three animals underwent splenectomy,
salpingo-oophorectomy and small bowel resection, and vessel seals
were studied histologically after a 7-day survival period for vessel wall
fusion, inflammation and fibrous organization. RESULTS: Seal
failure was 5.9% after BiClamp and 0% after LigaSure sealing. Burst
pressures of BiClamp-sealed arteries (842+117 mmHg) did not
differ from those of arteries sealed with LigaSure (856+102 mmHg);
however, they were significantly (p50.05) higher compared than
those of veins (155+26 and 216+71 mmHg). In addition, inde-
pendent of the two sealing devices thermal spread was found to be
increased in veins compared with arteries. Histological analysis after
7 days revealed appropriate healing of the vessel wall fusion,
including thrombus fibrosis, fibroblast proliferation and collagen
deposition. With both devices, however, the venous wall still
presented with massive inflammatory cell infiltrate. CONCLU-
SION: Our study indicates that the BiClamp device is as appropriate
as the LigaSure instrument to successfully ligate 2–7-mm arteries and
veins, demonstrating supraphysiological bursting strengths and
adequate luminal fusion healing. Of interest, veins are more prone to
collateral tissue damage and inflammatory wall infiltration.
17 A 20-YEAR EXPERIENCE OF LIVER TRAUMA
Frena A, Martin F, La Guardia G, Catalano P, General Surgery 2,
Regional Hospital, Bolzano, Italy
INTRODUCTION AND AIM: Liver trauma is a relatively frequent
surgical emergency with significant mortality and morbidity rates.
The management of liver injuries has dramatically changed in the
past two decades, especially in the treatment of blunt trauma.
PATIENTS AND METHODS: A database of 112 hepatic injuries
from 1984 to 2004 was analyzed. RESULTS: The majority of inju-
ries occurred as a result of road traffic accidents (39.3%), the second
cause was sport accidents (20.5%). Ninety-one patients (81.2%)
were stable at presentation to the hospital. In 94 patients (83.9%) the
liver injury was a component of multiple trauma. Ultrasonography
and CT scan was used as a diagnostic tool in 95% and 57%,
respectively. Operative management was undertaken in 68 patients
(60.7%). The overall mortality rate was 12.5%. CONCLUSION:
The treatment and outcome of liver injuries have really changed in 20
years. Most patients with liver trauma can be managed conserva-
tively. Operative management is associated with high mortality and
morbidity rates. CT of the abdomen should precede laparotomy,
even in some haemodynamically unstable patients, to facilitate the
best way of treatment.
18 ENDOMETRIAL CYST OF LIVER—A REVIEW
Yeluri S, Rao M, Ali A, Ching SS, Gledhill R, McMahon MJ,
Academic Unit of Surgery, General Infirmary at Leeds, Leeds, UK
INTRODUCTION AND AIM: Although the pelvis is the most
common site of occurrence of endometriosis, almost every site in the
body, with the exception of spleen, has occasionally been implicated.
Hepatic endometriosis is a rare occurrence and only a handful of cases
have been reported in the literature. The aim of this paper is to report
one such case and review literature behind this rare presentation.
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PATIENTS AND METHODS: This is a case report with a review
of literature from a university hospital setting of a 50-year-old lady
with an incidentally discovered cystic lesion of liver diagnosed as
an endometrial cyst on cytology. After recurrence following
minimally invasive surgery, the patient was successfully managed
conservatively. RESULTS: Review of the literature suggests that
most patients with hepatic endometriosis present with non-specific
abdominal pain unrelated to menstruation, unlike the classical
catamenial symptoms seen with pelvic and thoracic endometriosis.
Half of these patients have a significant history of pelvic endo-
metriosis and pelvic surgery. Malignant transformation has also
been reported once. Theories behind pathogenesis include coelomic
metaplasia, lymphovascular dissemination, iatrogenic injury and
retrograde menstruation. Though radiological features are non-
specific, repeating the scan at a different stage of the menstrual cycle
may be helpful. Gonadotrophin-releasing hormone analogues
(GnRH-a) and surgery may be considered as the mainstay of treat-
ment. CONCLUSION: Endometriosis should be considered in the
differential diagnosis of a cystic liver mass, especially in patients with
known pelvic endometriosis. A thorough history enquiring about
endometriosis, pelvic surgery and uterine intervention (e.g. curet-
tage) may help achieve the diagnosis in a patient presenting with an
unexplained cystic liver lesion.
19 PREDICTIVE FACTORS FOR OPERATIVE OR NON-
OPERATIVE MANAGEMENT OF BLUNT LIVER TRAUMA
Markogiannakis H2, Sanidas E1, Messaris E2, Tsiftsis D1,
(1) Department of Surgical Oncology, Herakleion Medical School,
University of Crete, Herakleion, Crete, Greece; (2) 1st Department
of Propaedeutic Surgery, Hippocration Hospital, University of
Athens, Athens, Greece
INTRODUCTION AND AIM: Non-operative management
(NOM) is considered to be the treatment of choice for carefully
selected patients with blunt liver trauma. The objective of this study
was to evaluate the factors that can safely predict NOM of blunt liver
trauma patients. PATIENTS AND METHODS: Our study is a
retrospective analysis of Trauma Registry data of all 55 consecutive
adult patients admitted with blunt liver injury to a Greek level I
trauma center over a 4-year period. RESULTS: Nineteen (34%) of
the 55 patients were immediately operated, whereas 36 (66%) were
initially selected for NOM. Systolic arterial pressure (p=0.04),
concomitant abdominal (p=0.04) and spinal cord injury (p=0.03)
were independent predictive factors for operative or non-operative
management of these patients. Patients with low systolic arterial
pressure, concomitant abdominal injury and spinal cord injury were
immediately operated. 33 of the 36 patients that were selected for
NOM were successfully treated conservatively, while 3 were finally
operated; thus, the rate of success of NOM was 92%. CONCLU-
SION: Non-operative management of carefully selected patients with
blunt liver trauma is safe and efficient. Systolic arterial pressure along
with concomitant abdominal and spinal cord injury are predictive
factors for operative or non-operative management of these patients.
20 PREDICTIVE VALUE OF INJURY SCORING
SYSTEMS AS CRITERION FOR NON-OPERATIVE
MANAGEMENT OF BLUNT HEPATIC TRAUMA
Markogiannakis H2, Sanidas E1, Messaris E2, Tsiftsis D1,
(1) Department of Surgical Oncology, Herakleion Medical School,
University of Crete, Herakleion, Crete, Greece; (2) 1st Department
of Propaedeutic Surgery, Hippocration Hospital, University of
Athens, Athens, Greece
INTRODUCTION AND AIM: Non-operative management
(NOM) is considered to be the treatment of choice for carefully
selected patients with blunt hepatic trauma. The aim of this study was
to evaluate the predictive value of injury scoring systems as criterion
for NOM of blunt hepatic trauma. PATIENTS AND METHODS:
Our study is a retrospective analysis of Trauma Registry data of all
adult patients admitted with blunt liver injury to a Greek level I
trauma center over a 4-year period. Trauma severity was estimated
with Injury Severity Score (ISS), Revised Trauma Score (RTS),
Trauma Score (TS), International Classification of Diseases – 9th
revision Injury Severity Score (ICISS) and Probability of survival
(Ps). RESULTS: Fifty-five consecutive patients were admitted to our
hospital with blunt hepatic trauma. Immediate operation based on
specific indications was decided for 19 patients (34%). These
patients had lower ICISS (p=0.03) than the 36 patients (66%) who
were selected for NOM. On the contrary, there was no significant
difference in ISS, RTS, TS and Ps between immediately operated
and NOM patients. CONCLUSION: ICISS is useful for selecting
patients with blunt hepatic trauma for NOM. Other injury scoring
systems commonly used to estimate the total severity of injury of
polytrauma patients such as ISS, RTS, TS and Ps cannot safely be
used as criteria for the decision to treat these patients operatively or
observationally.
21 THE CASE OF LIVER DUPLICATION
Beyayeva NV, Gubergrits N, Chair of Internal Diseases No 1,
Donetsk State Medical University, Donetsk, Ukraine
INTRODUCTION AND AIM: Liver anomalies occur very rarely,
and the development of an additional liver is not generally described.
PATIENTS AND METHODS: We observed in our clinic a patient
with liver duplication. RESULTS: Patient C, aged 32 complained of
heaviness in the right part of the abdomen after having meals
containing some fat and fried food and after some physical exertion.
He also complained of general weakness. During the neonatal period
he was operated on for pyelostenosis, liver anomaly having been
revealed by laparotomy. Sonography: two parts of liver paren-
chyma—that is in the right hypochondrium and the right half of
mesogastrium. These parts are connected by a thin intersection,
which is 2.5 cm thick. Under the lower portion of the pelvic cavity we
revealed the enlarged gallbladder with the diverticulum; under the
upper one we found a formation which was like wrinkled gallbladder.
Fibrogastroduodenoscopy showed two Vater’s papilla. Cholecysto-
graphy: the enlarged hypomotile gallbladder with the diverticulum on
the level of the iliac bone wing is contrasted. CT and liver scinti-
graphy confirmed the presence of the two portions of liver paren-
chyma. Doppler US: anomalous structure of liver vascular system in
both portions of liver parenchyma is like arch portocaval anasto-
mosis. We performed puncture biopsy of the upper and lower
portions of liver parenchyma (the results are like each other): there
was chronic hepatitis with the minimal activity. CONCLUSION:
Thus, this anomaly looks like Riedel’s lobe, but it is differentiatedd by
the presence of two Vater’s papilla, and by two gallbladders.
22 THE EXPERIENCE OF TREATMENT OF CHRONIC
VIRAL HEPATITIS C AMONG ELDERLY PATIENTS
Gubergrits NB, Lukashevich G, Chair of Internal Diseases No 1,
Donetsk State Medical University, Donetsk, Ukraine
INTRODUCTION AND AIM: Under interferon therapy of chronic
diffuse liver diseases connected to hepatitis C virus, accessory reac-
tions often occur. These reactions are especially severe among elderly
patients. The aim was to study the effectiveness of ursodeoxycholic
acid (Ursofalk) in elderly patients with viral hepatitis C. PATIENTS
AND METHODS: We observed 23 patients who were more than 65
years old. 18 of them suffered from chronic viral hepatitis C, 5 had
viral C hepatic cirrhosis. RNA of virus C was revealed in blood of all
patients. RESULTS: The activity of process among 15 patients was
minimal, another 8 patients had moderate one. All patients were
given Ursofalk 750 mg daily for a month and then 500 mg per 24 h
for 3 months. 20 patients with the analogous pathology were studied
under control. They were not administered interferon therapy
because of side effects and Ursofalk was not given to them. At
evaluation of results of treatment at 4 months those patients who
were given Ursofalk had authentic reduction of ALT, alkaline
phosphatase, the total and direct bilirubin of blood and the correction
of dysproteinemia. The patients in the control group had authentic
increase of ALT serum level and non-authentic tendency to increase
of the rest of the biochemical findings and aggravation of dyspro-
teinemia. Two patients treated by Ursofalk had negative results of
polymerase chain reaction (PCR), while patients in the control group
had the former results. CONCLUSION: Thus, Ursofalk therapy is
effective among the elderly people suffering from chronic diffuse liver
diseases caused by hepatitis C virus.
23 METABOLIC CHANGES IN THE PIG LIVER
DURING ISCHEMIA MEASURED BY MICRODIALYSIS
Thorsoe HJ, Mortensen FY, Funch Jensen P, Festersen M,
Rokkjaer M, Gastrointestinal Surgery L, Aarhus University Hospital,
Aarhus, Denmark
INTRODUCTION AND AIM: The aim of the present study was to
evaluate microdialysis as a method to measure metabolic changes in
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the pig liver during ischemia. PATIENTS AND METHODS: Ten
Landrace pigs, weighing 60 kg, were used for the experiments. A
midline laparotomy was performed under general anasthesia. Four
catheters for microdialysis were placed in the liver, one in each lobe.
Samples for determination of lactate, glucose, glycerol and pyruvate
were collected every 30 min. After 3 h total ischemia by way of the
Pringle maneuvre was performed. Hereafter measurements were
continued for 3 h. RESULTS: After 30 min of total ischemia all pigs
showed a significant increase in lactate and glycerol levels, and all pigs
showed a significant fall in pyruvate levels. Glucose levels showed a
tendency to decrease during ischemia. Different parts of the liver
showed the same metabolic changes during ischemia. CONCLU-
SION: Microdialysis is a reliable method for continously measuring
metabolic changes in the pig liver during ischemia.
24 DEVASCULARIZATION SURGICAL MODEL OF
ACUTE LIVER FAILURE IN MINI-PIGS
Ryska M3, Kieslichova E1, Pantoflicek T2, Ryska O3,
(1) Anestesiology, IKEM; (2) Surgery department, Central Military
Hospital; (3) 3rd Faculty of Medicine, Charles University, Prague 6,
Czech Republic
INTRODUCTION AND AIM: The study was designed to develop
a readily reproducible model of acute liver failure (ALF) in the mini-
pig, to gain an 8-h therapeutic window to mimic, as closely as
possible, acute liver failure in man. PATIENTS AND METHODS:
We used a reversible devascularization model of ALF in the mini-pig
involving hepatic artery ligation and established an end-to-side
portocaval anastomosis. Standard laboratory monitoring was com-
plemented with intracranial pressure (ICP) measurement.Twenty
mini-pigs (weight 25–30 kg) were used for the experiment. The
animals were divided into 3 groups: I, 10 animals in an experimental
group with ALF; II, 5 animals in an experimental group with ALF
and ICP measurement; III, 5 animals in a control group without
ALF. RESULTS: Laboratory testing has shown the significant
changes in levels of AST (33.44+39.96 vs 1.56+0.50 mmol/l),
lactate (2.97+1.16 vs 1.18+0.61 mmol/l), and ammonia (264.3+
93.05 vs 42.5+12.98 mmol/l) between ALF groups and controls
(p5001) 6 h after the operative procedure and significant changes in
hypoglycemia and intracranial pressure were found 4 h after the
operative procedure. The difference in Quick values (67.4+17.03 vs
75.2+2.68) was not significant. We assume that the therapeutic
window starts 4 h after the beginning of the experiment. CON-
CLUSION: Our devascularization model of ALF is simple and
readily reproducible. The therapeutic window occurring shortly after
surgery and persisting for a mean 9 h is suitable to evaluate bioarti-
ficial liver devices.
25 ASSESSMENT OF TREATMENT EFFICACY OF
HEPATITIS OR HEPATIC CIRRHOSIS WITH ESSENTIAL
PHOSPHOLIPIDS BASED ON RESULTS OF BLOOD
INTERFACIAL TENSIOMETRY
Gubergrits NB2, Lobas E1, (1) Department of Gastroenterology,
Donetsk Regional Hospital; (2) Donetsk State Medical University,
Department of Internal Diseases No. 1, Donetsk, Ukraine
INTRODUCTION AND AIM: The amount of surface-active
substances is changed in chronic hepatitis (CH) or hepatic cirrhosis
(HC). This contributes to changes in blood dynamic surface tension
(DST). The aim was to assess the efficacy of essential phospholipids-
based drug Essentialle N depending on DST indices. PATIENTS
AND METHODS: We examined 44 patients with CH and 32
patients with HC of alcoholic etiology. 38 patients received Essen-
tialle N; other patients received silimarine. Indices of interfacial
tensiometry were registered with the help of a computerized tensio-
meter MPT2 Lauda (Germany). We determined DST after t=
0.01 s (DST1), t=1 s (DST2), t=100 s (DST3) and assessed angle
of tensiogram curve slope (ATCS). RESULTS: Increase of DST1
and reduction of DST3 is characteristic for CH and HC patients, and
these data correlate with biochemical and morphological data. All
CH patients who received Essentialle N reached normalization of
interfacial tensiometry indices. In the group of HC patients ATCS
became normal in 40.0%, DST3 alone in 60.0% and both DST1 and
DST2 became normal in all HC patients who received Essentialle N.
In those receiving silimarine normalization of blood DST indices
were achieved rarely. CONCLUSION: Blood DST is an integral
index, which allows us to assess efficacy of treatment of CH and HC.
Essentialle N renders a positive therapeutic effect in treatment of
chronic diffuse diseases of the liver.
26 DISORDERS OF SMALL INTESTINE ABSORPTIVE
FUNCTION REVEALED BY MEANS OF D-XYLOSE TEST
FROM PATIENTS WITH CHRONIC LIVER DISEASES
Linevsky YV, Gubergrits N, Zagorenko Y, Chair of Internal Diseases
No 1, Donetsk State Medical University, Donetsk, Ukraine
INTRODUCTION AND AIM: Patients suffering from chronic
diffuse liver diseases have an impaired process of digestion, although
the absorptive function of the small intestine has not been studied yet.
The aim was to assess the absorptive function of the small intestine in
chronic diffuse liver diseases. PATIENTS AND METHODS: An
absorptive function of small intestine was studied with the help of the
D-xylose test in 86 patients who had chronic diseases of the liver such
as chronic hepatitis (n=60) and hepatic cirrhosis (n=26) in the
period of exacerbation. Biopsy of mucous membrane was taken
simultaneously. RESULTS: The verified reduction of D-xylose
excretion in urine in all observed groups with liver troubles was
revealed. This was more evident in cases of hepatic cirrhosis and less
evident in cases of chronic persistent hepatitis. The observed changes
indicate differences of small intestine disorders. Histological findings
of biopsies revealed the presence of small intestine changes in the
majority of patients examined on chronic ileitis. CONCLUSION:
Thus, the main reasons for small intestine absorptive function
disorders in patients with liver troubles appear to be latent inflam-
matory dystrophical changes in the mucous membrane of small
intestine. Accompanying changes of small intestine of patients having
chronic liver troubles should be taken into account in treatment of
this pathology.
27 APOPTOSIS AND HSP70 EXPRESSION IN
TRANSITION ZONE FOLLOWING RADIOFREQUENCY
ABLATION IN PORCINE LIVER
Rai RR4, Robertson C1, Flecknell PA1, Robertson H2, Burt AD2,
Manas D3, (1) Comparative Biology Unit, University of Newcastle,
UK; (2) Pathology, University of Newcastle, UK; (3) Department of
HPB Surgery & Transplantation, Freeman Hospital, Newcastle,
UK; (4) Dudley, UK
INTRODUCTION AND AIM: Following radiofrequency ablation
in ex vivo human liver, we have identified a transition zone of tissue
between the necrotic liver and viable normal liver parenchyma using a
vital stain. The aim of this study was to investigate expression of
HSP70 on hepatocytes in this zone as well as to identify any ongoing
apoptosis in the zone of transition. PATIENTS AND METHODS:
Five landrace pigs underwent RFA under general anaesthesia. In
total 3 lesions were created in the liver using RFA generator. Four
pigs were sacrificed 30 min after the end of the experiment. One pig
was revived and sacrificed 5 days later. Lesions were excised and
HSP70 expression was studied in tissues obtained from the centre of
the lesion and from the margin of ablated tissue using TUNEL
staining. HSP70 expression was also studied. RESULTS: There was
no evidence of apoptosis or HSP70 expression in the tissues obtained
from the pigs which were sacrificed 30 min following ablation but in
tissues obtained from the pig that was revived and sacrificed 5 days
later there was evidence of apoptosis of hepatocytes as well as
increased HSP70 expression on the hepatocytes in the transition
zone. CONCLUSION: Reperfusion following RFA induces
increased HSP70 expression and apoptosis in the transition zone.
This suggests sublethal cellular injury. Increased HSP70 expression
will make these cells more susceptible to cytotoxic cellular killing thus
improving the effects of RFA. The transition zone needs further
study following ablation of liver tumour.
28 RADIOFREQUENCY ABLATION OF PRIMARY AND
METASTATIC LIVER TUMORS—A 4-YEAR EXPERIENCE
Ribeiro MAF Jr5, Gama-Rodrigues J1, Habr-Gama A1, Caib E,
Fonseca A3, d’Ipollito G4, Saad W2, (1) Gastrointestinal Surgery,
Hospital das Clinicas; (2) Liver Surgery, Hospital das Cinicas;
(3) Liver Surgery, Hospital Sao Luiz; (4) Radiology, Hospital Sa˜o
Luiz; (5) Hospital das Clinicas e Sa˜o Luiz Liver and Portal
Hypertension Surgery, Sa˜o Paulo, Brazil
INTRODUCTION AND AIM: Radiofrequency ablation of primary
and metastatic liver tumors has been shown to be one of the
promising new modalities to treat or to palliate liver tumors. It has
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been used as a bridge to liver transplantation as well as an approach to
recurrent tumors after resection. PATIENTS AND METHODS:
We present a series of 78 cases, 39 females and 39 males with a mean
age of 61 years. RFA was used either by laparotomy or percuta-
neously to treat 117 lesions. There were 32 cases of hepatocellular
carcinoma, 35 metastases of colorectal cancer and 11 cases of other
tumors. RESULTS: The mean number of lesions treated were 1.5
per case with an average size of 3.6 cm per lesion. All liver segments
were compromised, especially IV, VII, VIII. The morbidity was
28% and the mortality was 2.5%. In 20.5% of the cases we were
able to find recurrence after the procedure, with a mean time of
10.5 months. CONCLUSION: The RFA procedure is safe, can be
performed in different ways and in the group of patients who are
candidates for liver transplantation, while waiting for the organ. For
metastatic diseases it is not a substitute for surgery but can be used in
patients who cannot be operated.
29 FUNCTIONAL PATHOLOGY OF SMALL INTESTINE
OF PATIENTS SUFFERING FROM CHRONIC VIRAL
HEPATITIS B
Gubergrits NB, Belyayeva N, Linevsky Y, Chair of Internal Diseases
No. 1, Donetsk State Medical University, Donetsk, Ukraine
INTRODUCTION AND AIM: Not enough is known about the
state of parietal digestion in chronic viral hepatitis. The aim was to
study a functional state of jejunal mucosa in patients with chronic
viral hepatitis B. PATIENTS AND METHODS: Biopsy of mucous
membrane of the primary section of small intestines with the further
examination of lactase, maltase, saccharase, glycine-L-leucine
dipeptidase and monoglyceride lipase activity in its homogenate was
carried out for 43 patients with chronic viral hepatitis B. A condition
of membrane and cavitary digestion on resorption of amylase and
lipase in bioptate was determined. Absorptive function of small
intestine by way of D-xylose test, the contents of enterokinase and
alkaline phosphatase were studied. RESULTS: An increased
amylase and lipase activity of membrane and cavitary digestion of
small intestine, a reduction of glycine-L-leucine dipeptidase and
monoglyceride lipase production, an increased output of saccharase
were revealed. Slight insufficiency of small intestine absorptive
function was also observed. CONCLUSION: The above-mentioned
disorders of small intestine should be taken into account in treatment
of patients with chronic viral hepatitis B.
30 PHYTOHEPATOPROTECTORS IN TREATMENT
OF CHRONIC DIFFUSE LIVER DISEASES
Gubergrits NB, Zagorenko Y, Chair of Internal Diseases No. 1,
Donetsk State Medical University, Donetsk, Ukraine
INTRODUCTION AND AIM: The advantages of the combined
phytohepatoprotectors are as follows: good endurance, absence of
toxic effects, rarity of allergic reactions, simultaneous effect on some
pathogenic sections of the disease. The aim was to study the effec-
tiveness of phytohepatoprotectors in chronic diffuse liver diseases.
PATIENTS AND METHODS: Under our observation there were
62 patients with chronic hepatitis and hepatocirrhosis with a minimal
activity of toxic and alcohol etiology. 34 of the examined patients
took the combined phytohepatoprotectors Hepatofalk Planta or
Hepabene (the first group). The rest of 28 patients took non-herbal
phytohepatoprotectors, infusive therapy, polyvitamins (the second
group). RESULTS: The treatment results in the first group were
significantly better than those in the second group. The marked
clinical manifestations were especially reduced among those patients
who took phytohepatoprotectors: the heaviness in the right hypo-
chondrium, asthenia, dyspepsia and so on. In three weeks after the
treatment 28 patients (82%) of the first group achieved normalization
of biochemical findings (aminotransferases, alkaline phosphatase,
lactate dehydrogenase (LDG), gamma-glutamyltranspeptidase
(GGT), serum protein, proteinogram). The most marked effect was
achieved among the patients with chronic hepatitis in combination
with the pathology of the bile ducts. The results of the treatment of
the patients in the second group were significantly worse both in
relation to clinical and biochemical manifestation of the disease.
There was noted the increase of alanine-aminotransferase and GGT
among four patients (14%) of the second group. CONCLUSION:
Thus, the preparations of choice are the combined phytohepato-
protectors among the patients with non-viral diffuse liver diseases
with minimal activity.
31 LIVER LESION IN PATIENTS WITH NON-SPECIFIC
ULCERATIVE COLITIS
Gubergrits NB, Zagorenko Y, Chair of Internal Diseases No. 1,
Donetsk State Medical University, Donetsk, Ukraine
INTRODUCTION AND AIM: Non-specific ulcerative colitis may
be accompanied by liver pathology, which means extraintestinal
manifestations of the main disease. The aim was to study peculiarities
of liver lesions in non-specific ulcerative colitis. PATIENTS AND
METHODS: We observed 38 patients with non-specific ulcerative
colitis. RESULTS: Adipose hepatosis, which clinically presented
with hepatomegalia, dyslipidaemia and an increase in the intensity
of the sonographic picture of hepatic tissue, was diagnosed in 19
patients. In the blood chemistry there was a characteristic rise in the
activity of gamma-glutamyltranspeptidase. The diagnosis was con-
firmed by punch biopsy of the liver. 8 patients had hepatitis with
minimal or moderate activity. Among the signs of the clinical mani-
festations the following symptoms predominated: asthenia, dys-
pepsia, increased liver size and painful palpation. The results of
biochemical analysis of the blood showed the presence of moderate
cytolysis and dysproteinaemia. Different variants of dystrophy of the
hepatocytes and portal field infiltration were revealed by studying the
liver bioptate. Chronic hepatitis with significant activity was diag-
nosed in 4 patients with expressed biochemical signs of cytolysis,
bilirubinaemia and a fall in the synthesizing function of the liver. The
diagnosis was confirmed by the following morphological picture:
‘bridge-like’ necrosis, portal, periportal and also intralobular infil-
tration. Micronodular hepatic cirrhosis was diagnosed in one patient,
macronodular disease in one, primary sclerosing cholangitis in two,
and hepatic amyloidosis in one patient. Liver abscess as well as
cholangiogenic liver cancer was revealed in a single case.
CONCLUSION: The diversity of the variants of liver lesion in non-
specific ulcerative colitis needs a differential approach in diagnosis
and treatment.
32 THE USE OF OCTREOTIDE FOR THE TREATMENT OF
CHRONIC ABDOMINAL PAIN AFTER LIVER RESECTION
Severtsev AN, Tchudaev D, Mejgih T, HPB-Surgery, Central
Clinical Hospital #1 OAO RZD, Moscow, Russia
INTRODUCTION AND AIM: One of the causes of chronic
abdominal pain after abdominal surgery is the development of
abdominal adhesions. There are some publications about the
prevention and treatment role of octreotide in case of the develop-
ment of abdominal adhesions. According to various data liver
resection is the ideal clinical model which gives the maximal devel-
opment of abdominal adhesions. The purpose of this clinical study is
to assess the use of octreotide for abdominal adhesion prevention and
the treatment of chronic abdominal pain. PATIENTS AND
METHODS: From December 1994 until May 2001, 135 patients
with liver tumors were surgically treated (resections) at the Surgical
Department/Liver Unit of the MCRG (Moscow, Russia). The main
(31) and control (44) groups were compared for the use of octreotide.
The mean age of patients in the groups was 57+9 and 55+14 years
and male/female ratio was 14/17 and 17/27, respectively. The mean
octreodide (Sandostatin) dose was 0.1 mkg per day subcutaneously 3
days before surgery and 14 days after. The criteria of octreodide
effectiveness were the absence of intestine obstruction and no need
for postoperative laparotomy, the presence of chronical abdominal
pain (1 month after surgery) which demands the use of analgetics.
RESULTS: All general criteria were the same for both groups.
Adhesive intestinal obstruction developed in 7 patients in the control
group and in no patients in the main group. Laparotomy was used in
5 patients. Postoperative pain developed in 14 patients in the control
group and 1 in the main group. CONCLUSION: Octreotide could
be used for the treatment and prevention of abdominal adhesion
formation after liver resections and the subsequent treatment of
chronic abdominal pain after such surgery.
33 SPONTANEOUS RENAL RUPTURE IN BUDD-CHIARI
SYNDROME
Calheiros JPF, de Sa Ribeiro FA, Cordona Machado AL, Oliveira
Gonc¸alves S, Fernandes Araujo GM, General Surgery, Bonsucesso
General Hospital, Rio de Janeiro, Brazil
INTRODUCTION AND AIM: Budd-Chiari syndrome is char-
acterized by hepatic venous outflow obstruction, causing a hetero-
geneous group of disorders which includes portal hypertension. The
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authors report a case of an uncommon clinical manifestation, spon-
taneous renal rupture, and its association with portal hypertension
and Budd-Chiari syndrome is reviewed in the literature currently
available. PATIENTS AND METHODS: The authors report the
case of an 18-year-old male admitted to the Bonsucesso General
Hospital’s Emergency Department presenting spontaneous retro-
peritoneal hemorrhage due to renal rupture and treated with surgical
nephrectomy. A literature review, using MEDLINE, was performed
for spontaneous renal rupture and its association with portal hyper-
tension and Budd-Chiari syndrome. RESULTS: Spontaneous renal
rupture is a rare clinical finding with varied causes. Only one single
report was obtained for the causative association between portal
hypertension and spontaneous renal rupture. CONCLUSION:
Spontaneuos renal rupture, like other causes of retroperitoneal
hemorrhage, is an extremely rare complication of portal hyperten-
sion. The association between spontaneous renal rupture and portal
hypertension due to Budd-Chiari syndrome has not been reported in
the literature before.
34 ALLOGENIC TRANSFUSION IN HPB PATIENTS:
IMPLICATIONS
Serrablo A, Miguel Servet University Hospital, Zaragoza, Spain
INTRODUCTION AND AIM: There is currently a growing inter-
est in the analysis of the harmful effects of allogenic blood transfusion
(ABT) and of immunological type and the benefits of the blood-
saving methods. The effects of the implementation of integrated
blood saving programs are highlighted in them, and some of them
include: a reduction in the nosocomial infection rate, morbidity/
mortality rates, ICU and hospital stay days, longer disease-free
period in oncologic patients, reduced recurrence, improved liver
parenchyma regeneration. Although in cancer surgery, the greatest
concern is for immunomodulation induced by ABT (ATIS) and its
possible repercussions, possibly, in hepatopancreato-biliary surgery,
this effect should be thoroughly assessed even if they are not cancer
patients. It is known that immunomodulation is currently not fully
understood, but there are data and clinical observations that go
beyond presumption; the changes in the balance between Th1 and
Th2 responses possibly lead to susceptibility to the disease states. In
hepatopancreato-biliary surgery, particularly liver surgery, a signifi-
cant effort has been made to reduce allogenic blood exposure. Many
authors show the need for reducing it to improve the outcome of this
type of surgery. PATIENTS AND METHODS: To comment and
analyze the implications on the basis of our data and to show current
opinion about allogenic transfusion in HPB patients. RESULTS:
Liver resections are a significant method of treatment for primary and
secondary liver tumors. Major vascular structures, mainly suprahe-
patic veins, accessory veins and inferior vena cava, are strong reasons
for bleeding, sometimes abundantly, during resection. A tearing or
any event can dramatically alter the blood loss, by increasing, as in the
study by Bui, from 1000 ml to 4100 ml. As the loss of a large volume
of blood is correlated to morbidity, it could be stated that in these
cases the outcome of the patient has already been modified during the
procedure. In colorectal oncology surgery, it has been published that,
as in orthopedic or heart surgery, the allogenic transfusion-induced
inmunosupression (ATIS) is dependent on the volume transfused,
clearly related to intraoperative losses and preoperative hemoglobin,
and the relative risk of suffering nosocomial infection or recurrent
and distance metastasis changes. In liver surgery, the variability of
this volume, the ranges published, are large, from 0 to 14 units, in
most series. The mortality in the study by Figueras et al. is 14% when
the volume transfused is 3 or more units and 1.6% when lower,
evidencing the immunomodulating effect according to the volume
transfused. In surgery of the pancreas, no data have been found
assessing the harmful effects of ABT, maybe, particularly in patients
with cancer of this organ, due to the particular circumstances of the
time of diagnosis and the type of surgery, with a morbidity close to
50% and a mortality close to 10%, making difficult the application of
techniques to minimize the transfusion of blood derivatives. These
patients usually suffer multifactorial anemia and a marked nutritional
deficit, if they do not suffer active or recent biliary infection, some-
times leading to the diagnosis. The possible impact of ABT in
nosocomial infection (NI) could be determinant to try to modify the
estimated reducible percentage of 32% of them. In this setting, we
will report the results of two prospective studies performed in our
unit. In the first, 468 patients during 1 year were included and in the
multivariable analysis, the allogenic transfusion was the only
amendable independent factor for reducing the nosocomial infection
rate, with OR=3.554. In the second, hepatic resections for colorectal
metastasis were analyzed and we found that those patients that suffer
allogenic transfusion had bigger NI and morbidity rate and longer
length of UCI and hospital stay in comparison with those who
underwent autotransfusion. We found the same results as Kooby et al.
They concluded that perioperative blood transfusion is a risk factor
for poor outcome after liver resection and that blood conservation
methods should be used to avoid transfusion. CONCLUSION: If we
reduce the allogenic transfusion rate we will improve our patients’
outcome and reduce the NI, morbidity and mortality rates. From a
multidisciplinary oncologic point of view, we have several approaches
to achieve the cure of our patients: radical surgery (R0), chemo-
therapy and radiotherapy in some cancer types. We believe that there
is another complementary option that consists of avoiding or redu-
cing the allogenic transfusion, allowing that the immune system
concludes and support to the radical surgery.
35 HEPATOCYTE INJURY ASSOCIATED WITH
EXCESSIVE GENERATION OF PORTAL CYTOKINE IN
ISCHEMIA/REPERFUSION (I/R) OF HUMAN LIVER
Kim YI, Kyungpook National University, Biomolecular Engineering
Center, Department of Surgery, Taegu, South Korea
INTRODUCTION AND AIM: Clinical implications of acute
reactant cytokine responses need to be clarified in the setting of I/R of
human liver during liver resection. PATIENTS AND METHODS:
Serial samples of portal and systemic venous blood were obtained
and were analyzed for the cytokine activities at the time points, before
(I), at the end of hepatic pedicle clamping (II) and 1 h (III) after
continuous hepatic inflow occlusion (HIO) in 25 patients with
normal backgroud liver who underwent elective hepatectomy (15
major and 10 minor resections). The interleukin-6 (IL-6) responses
(ELISA) were compared with HIO, portal pressure on clamping
(PVP) and postoperative liver function tests. RESULTS: Portal IL-6
levels rose significantly during HIO as compared with the systemic
levels (562+/7431 vs 346+/7262 pg/ml, p50.02). The portal IL-
6 concentrations during liver resection (time points II and III) were
significantly correlated positively with postoperative serum levels of
ALT (day 1705+/71023U/L), AST (892+/71255), and maxi-
mum bilirubin (2.5+/72.5 mg/dl) (p50.002). The PVP (500+/
7127 mmH2O) and HIO(48+/79 min) had also shown a sub-
stantial correlation with the IL-6 levels at time point II (p50.05).
CONCLUSION: These results suggest that overproduction of acute
reactant cytokine from the portal circulation in hepatic I/R is posi-
tively related to the postoperative hepatocyte injury in humans.
36 CHANGES IN BIOIMPEDANCE OF RABBITS’ LIVER
DURING ISCHEMIA- EPERFUSION INJURY AND CELL
VIABILITY
Yun SS1, Kim HJ1, Lee DS1, Shin HJ2, Ahn HS2, Kim JY3, Kim JH4,
(1) Surgery; (2) Institute of Biomedical Engineering; (3) Physiology;
(4) Biochemistry, Yeungnam University Hospital, Taegu, South
Korea
INTRODUCTION AND AIM: During liver resection and liver
transplant, the liver is damaged by ischemia-reperfusion injury. Until
now, there has been no approved method to measure or predict the
extent of liver injury during the operation. This is the preliminary
study to make the real-time monitoring system by quantification of
bioimpedance and ischemia-reperfusion injury in liver. PATIENTS
AND METHODS: Ten New Zealand White rabbits (male 3.5–
4.0 kg) were divided into two groups. In group 1 (n=5), we induced
30 min ischemia and 20 min reperfusion. In group 2 (n=5), we
induced 120 min ischemia. We measured liver tissue bioimpedance
(120 Hz–1000 KHz) at 5-min intervals with two mono-polar needles
coated with white gold using an LCR meter (GS-4311B, Ando,
Japan). Cell viability was assessed by metabolic capacity of fatty acid
(palmitic acid metabolic rate) and histologic examination (H/E stain)
at 30-min intervals during ischemia. RESULTS: Bioimpedance was
changed significantly (p50.05) during ischemia at lower frequency
compared with those of higher frequency. In group 1, the levels of
bioimpedance (120 Hz) at pre-ischemia, 5, 10, 15, 20, 25 and
30 min after ischemia were 7.3+/71.5, 9.6+/70.8, 10.5+/71.2,
12.0+/71.4, 13.6+/73.0, 14.8+/73.7 and 16.3+/74.9 (mean
+/7SD), respectively. The level of bioimpedance returned to
baseline level after reperfusion. In group 2, the level of bioimpedance
(120 Hz) increased gradually after ischemia for 1 h. After 1 h, the
level of bioimpedance had a tendency to maintain plateau. Palmitic
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acid oxidation rates were not changed significantly during 120 min of
ischemia and there were no differences in histologic examinations.
CONCLUSION: We found a possible role of bioimpedance to
measure and predict the extent of ischemia-reperfusion injury.
However, we need further study to clarify the relationship between
bioimpedance and ischemia-reperfusion injury and we also need
further study to prove the cause of bioimpedance change during
ischemia-reperfusion injury.
37 ISCHEMIC PRECONDITIONING IMPROVES BILE
FLOW AFTER ISCHEMIA AND REPERFUSION INJURY
TO THE LIVER IN RATS
Nieuwenhuijs VB1, Padbury R1, Hughes R2, Stahl J3, Barritt G2,
(1) Surgery, Flinders Medical Centre; (2) Medical Biochemistry,
Flinders University School of Medicine; (3) Pathology, Flinders
Medical Centre, Bedford Park, Australia
INTRODUCTION AND AIM: Ischemia and reperfusion (IR)
injury to the liver is a well known phenomenon in liver transplant and
major liver resections and trauma. Ischemic preconditioning (IPC)
potentially attenuates IR injury. While there are many proposed
mechanisms to explain damage caused by IR and how this may be
alleviated by IPC, these are generally not well understood. The
reduction of bile flow following IR injury may lead to intrahepatic
cholestasis and secondary liver failure. There have been few studies of
the effects of an IPC regime on bile flow in liver models reflecting the
clinical situation. The aim was to elucidate the effect of IPC on bile
flow after IR injury in an intact rat liver model and to investigate the
intracellular mechanisms involved. PATIENTS AND METHODS:
Three groups of Hooded Wistar rats were studied. Group 1 (n=5)
were controls (selective bile duct cannulation (BDC) of the left lateral
and median lobes, 2-h measurement of bile flow). Group 2 (n=7)
received IR injury (BDC; 45-min clamping of portal vein (PV) and
hepatic artery (HA) to the left lateral and the median lobes followed
by 60 min of reperfusion). Group 3 (n=7) were pre-treated with IPC
(BDC; 10 min of PV and HA clamping followed by 10 min of
reperfusion prior to 45 min ischemia and 60 min reperfusion). Bile
flow was measured at 5-min intervals. Serum AST, ALT and LDH
levels were measured at the beginning and at the end of the experi-
ment. Liver histology was examined by H&E staining. F-actin dis-
tribution was measured using confocal fluorescence microscopy after
staining with Texas Red-X phalloidin. RESULTS: Ischemia reduced
bile flow to nil and bile flow did not recover after reperfusion
(p50.001 group 2 vs controls). IPC significantly improved bile flow
during reperfusion (p50.05 group 3 vs group 2). IPC did not
significantly reduce ALT, AST and LDH levels. Light microscopy
showed mild portal inflammation and hepatocyte damage in group 2;
this was less obvious in group 3. Cellular F-actin distribution did not
differ between groups. F-actin was located around the peripheral cell
membrane and the bile canaliculus. CONCLUSION: IPC signifi-
cantly improves bile flow after warm ischemia to the liver in rats.
F-actin distribution was not significantly altered by IR or IPC. Future
experiments are directed at elucidation of the mechanisms, includ-
ing the roles of F-actin, cytoplasmatic Ca2+ and Ca2+ regulatory
enzymes.
38 SPLENORENAL SIDE-TO-SIDE SHUNT FOR
EXTRAHEPATIC PORTAL VEIN THROMBOSIS
Wolff M, Schaefer N, Hirner A, Surgery, University of Bonn,
Bonn, Germany
INTRODUCTION AND AIM: In contrast to cirrhotic portal
hypertension, extrahepatic portal hypertension (EPH) due to chronic
thrombosis of the portal vein and its tributaries is rare and may occur
in young patients with well preserved liver function. Herein, our long-
term results with spleno-renal side-to-side shunt (SRSS), which was
first described by Cooley in 1963 for cirrhotic portal hypertension,
are reported. PATIENTS AND METHODS: From 1989 to 2004 a
group of 131 patients with EPH were treated by devascularization
and shunt procedures. In 32 patients a SRSS was applied. The
indications for SRSS (mean age 21, range 2–69) were recurrent
variceal bleeding (n=28) or primary prophylaxis in patients on
warfarin (n=4). Follow-up included SF-36 and Reitan-test for
quality of life and subclinical encephalopathy (HE) after 6 and 12
months. Shunt patency was assessed by Doppler sonography, by
helical CT scan or MR angiography when necessary. RESULTS: All
patients were alive after a mean follow-up of 51 (range 6–92) months
without evidence of recurrent bleeding and with excellent quality of
life. There was no clinical or subclinical HE with hemodynamically
total shunts (portosystemic pressure gradient after shunt (4+3
mmHg) in patients with normal liver histology. In one 13-year-old
child with congenital liver fibrosis episodic HE developed and the
SRSS was successfully changed to a selective DSRS. CONCLU-
SION: In patients with portal vein thrombosis, normal liver function,
and a patent splenic vein an SRSS can be applied with a low proce-
dural and follow-up complication rate. Quality of life becomes better
with time by decreasing fear of recurrent bleeding and repeated
endoscopy. In thrombophilic disorders oral anticoagulation becomes
possible, thus providing a better chance to avoid further thrombosis
of the portal system.
39 DUAL LIGATION OF PORTAL VEIN AND
HEPATIC ARTERY IS NOT MORE EFFECTIVE
THAN PORTAL VEIN LIGATION ALONE IN
INDUCING CONTRALATERAL LIVER HYPERTROPHY
IN A RAT MODEL
Vetela¨inen R, Dinant S, van Vliet A, van Gulik T, Surgery, Surgical
Laboratory, Academic Medical Center, Amsterdam, The
Netherlands
INTRODUCTION AND AIM: Dual embolization of hepatic artery
and portal vein has been proposed to enhance liver regeneration and
to gain tumor destruction prior to resection. However, the proin-
flammatory effect of dual embolization is unclear. This study eval-
uated the effect of portal vein ligation (PVL) compared to a dual
ligation of the hepatic artery and portal vein on liver regeneration and
on inflammatory response in a rat model of portal vein embolization.
PATIENTS AND METHODS: 5 groups were studied: laparotomy
only, a single hepatic artery ligation, a single portal vein ligation, dual
ligation of both artery and vein simultaneously (DUAL0) or with 48-
h interval (DUAL48). Rats were sacrificed 1, 2 or 14 days after
surgery (n=6/group). We assessed liver regeneration (regenerating
liver mass, proliferation index: MIB-5), inflammatory response (IL-
1beta and TNF-alpha in plasma and liver), synthesis function
(prothrombin time: PT-TT), hepatocellular damage (ALT, necro-
sis) and apoptosis (caspase-3). RESULTS: After 24 h the MIB-5
index was increased in the DUAL and DUAL48 groups compared
with PVL (p50.05); however, there was no difference in regenerat-
ing liver volume after 14 days (p=0.06). After DUAL0 and
DUAL48, TNF-alpha and IL-1beta were significantly increased in
plasma and regenerating liver compared with PVL (p50.05). Also,
caspase-3 positive cells were increased at 24 h and 48 h in both dual
ligated groups compared with PVL (p50.05). PT-TT stayed
prolonged until 14 days after DUAL0 and DUAL48 (p50.05).
CONCLUSION: Dual ligation is as effective as portal vein ligation in
inducing liver regeneration. An additional hepatic artery ligation
leads to both local and systemic inflammatory response impairing
synthesis function.
40 MUCINOUS CYSTADENOMAS IN LIVER AND
PANCREAS FEATURE A COMMON ORIGIN FROM
GONADAL EPITHELIUM DURING FETAL DEVELOPMENT
Erdogan D3, Lamers WH1, Offerhaus GJA2, Busch OR3, Gouma
DJ3, van Gulik TM3, (1) Department of Anatomy and Embryology;
(2) Department of Pathology; (3) Department of Surgery,
Academic Medical Center-University of Amsterdam, Amsterdam,
The Netherlands
INTRODUCTION AND AIM: Mucinous cystadenomas of liver
and pancreas are rare cystic neoplasms which contain ovarian stroma
(OS) and tend to occur more often in middle-aged women. The aim
of this study was to show that these tumors have a common origin
from gonadal epithelium in early fetal development, explaining the
presence of OS. PATIENTS AND METHODS: From 1997 to
2004, 21 female patients presented with mucinous cystadenomas
with OS (11 in liver of which one cystadenocarcinoma and 10 in
pancreas of which one cystadenocarcinoma). The regional differ-
ences in morphology of the peritoneal cavity epithelium and the
position of the gonads in relation to the embryonic liver, pancreas
and spleen were examined in embryos at 5–8 weeks development.
RESULTS: In all patients, OS could be identified, also in the 2
patients with mucinous cystadenocarcinomas as is compatible with
the pre-malignant nature of mucinous cystadenoma. In the fetal
period before the gonads descend, these are situated directly dorsal to
the liver, tail of the pancreas and the spleen, but are separated
from these organs by the peritoneal cavity. The cells covering
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the gonads in the urogenital folds may become detached on physical
contact with a neighbouring organ. They then lodge into that organ
giving rise to a cystadenoma with OS. CONCLUSION: Our findings
suggest that mucinous cystadenomas of pancreas and liver have a
common origin in the epithelial cells that cover the embryonic gonads
in early fetal life. These covering cells are easily mobilized and lodge
in adjacent liver or pancreas where they give rise to mucinous
cystadenomas with OS.
41 IMPROVEMENT OF NONALCOHOLIC
STEATOHEPATITIS IN SEVERELY OBESE PATIENTS AFTER
MASSIVE WEIGHT LOSS INDUCED BY GASTROPLASTY
Papakonstantinou A1, Stratopoulos C1, Terzis I1, Spiliadi C2,
Dimitriades G3, Komesidou V4, Kitsanta P2, Argyrakos T2,
Argyrakos T2, Hadjiyannakis EJ1, (1) First Department of Surgery &
Transplant Centre; (2) Department of Cellular Pathology;
(3) Second Academic Department of Internal Medicine;
(4) Department of Dietetics, Evagelismos Hospital of Athens,
Athens, Greece
INTRODUCTION AND AIM: Nonalcoholic steatohepatitis
(NASH) is common in the morbidly obese. The purpose of this study
was to evaluate the alterations in liver histology and biochemistry
with massive weight loss in severely obese patients following Mason’s
vertical banded gastroplasty. PATIENTS AND METHODS: This
prospective study included 51 non-diabetic, non-alcoholic, severely
obese patients with a mean age of 33.92 years, a mean body weight of
150.92 kg and a mean body mass index (BMI) of 52.8 kg/m2.
RESULTS: At entry, liver histology was abnormal in 50 patients.
Steatosis and steatohepatitis were present in 98.03% of the subjects,
with the majority having grade 3. Fibrosis was found in 94.1% of the
patients, with the majority having stage F2. Lipogranulomas and
regenerative activity were found in 56.9% and 41.2% of patients.
During the weight-losing period, excess weight loss of 66% had been
achieved (p50.001). A significant improvement was noted regarding
steatosis, steatohepatitis, lipogranulomas (p50.001) and fibrosis
(p=0.002). Regenerative activity was markedly increased, but did
not reach statistical significance (p=0.053). A significant correlation
between the reduction of BMI and the decrease of steatohepatitis was
noted (r=0.354, p=0.011). Fasting serum glucose, lipids, lipopro-
teins, transaminases, gamma-glutamyl transpeptidase, alkaline
phosphatase and fibrinogen were significantly improved at the time of
the second biopsy. CONCLUSION: Bariatric surgery is the best and
recommended treatment for NASH in the non-diabetic, non-alco-
holic, severely obese patient.
42 THE SEGMENTS OF THE HEPATIC VEINS—IS
THERE A SPATIAL CORRELATION TO THE
COUINAUD LIVER SEGMENTS?
Fischer L2, Thorn M1, Neumann JO2, Heimann T1, Grenacher L3,
Meinzer HP1, Friess H2, Bu¨chler MW2, (1) Department MBI,
DKFZ Heidelberg; (2) Department of Surgery, University of
Heidelberg; (3) Department of Radiology, University of Heidelberg,
Heidelberg, Germany
INTRODUCTION AND AIM: The exact definition of venous
segments/subsegments and their spatial correlation to Couinaud liver
segments has an increasing clinical importance especially against the
background of living-related liver transplantation. PATIENTS AND
METHODS: In 3-D liver models of 19 patients volume, position and
shape of 3 venous segments, 6 venous subsegments, 8 Couinaud
segments and 8 portal vein segments were defined and compared
with each other. RESULTS: The right hepatic vein covers with
539.8 ml+/7119.5 ml (47.1%) the largest part of total liver volume
followed by the middle hepatic vein 372.7 ml +/7151.1 ml
(32.5%), and the left hepatic vein 248 ml +/775.9 ml (20,4%).
Within these 3 venous segments the Couinaud/portal vein segments
2, 3, 5, 7, and 8 have an identical positional assignment, whereas the
Couinaud/portal vein segments 4a, 4b, and 6 showed significant
positional differences (p50.03). The size of venous subsegments
reached from 79.3 ml to 337 ml. There is no positional correlation
between venous subsegments and Couinaud segments (kappa
50.75). In contrast, venous segments/subsegments which reflect
either liver half/liver lobe have an identical volume, shape and posi-
tion compared to the corresponding Couinaud segments (kappa
40.75). CONCLUSION: The venous segments distinguish liver
areas divided by the left and middle hepatic vein in exactly the same
pattern as Couinaud segments do. However, the comparison of shape
and position of venous subsegments showed no correlation with the
Couinaud segments.
43 EX SITU RESECTION TECHNIQUES AND LIVER
AUTO-TRANSPLANTATION: LAST RESOURCE FOR
OTHERWISE UNRESECTABLE MALIGNANCY
Gruttadauria S2, Marsh W1, Gridelli B2, Marcos A1,
(1) Transplantation, University of Pittsburgh Medical Center;
(2) Abdominal Transplant Surgery, IsMeTT-UPMC ITALY,
Palermo, Italy
INTRODUCTION AND AIM: Ex vivo liver resection and hepatic
auto-transplantation allow treatment of otherwise unresectable
hepatobiliary malignancy. Recently improvement in outcomes in
selected cases has been reported. The aim of this study is to describe
our experience with two cases where we applied the combination of
the ex situ resection with hepatic auto-transplantation for intended
cure of two otherwise untreatable malignancies. PATIENTS AND
METHODS: A 41-year-old Caucasian male with diagnosis of
cholangiocarcinoma type IV according to Bismuth classification after
two previous exploratory laparotomies, underwent total hepatectomy
and ex vivo extended left lobectomy with reconstruction of the portal
vein with autologous iliac vein graft, auto-transplantation, aorto-
saphenous to right hepatic artery bypass, and Roux-en-Y hepatico-
jejunostomy. A second patient, a 58-year-old Caucasian male with a
diagnosis of recurrent leiomyosarcoma of the suprahepatic inferior
vena cava after two previous operations, underwent total hepa-
tectomy and ex vivo resection of a segment of supra hepatic inferior
vena cava and auto-transplantation with intra-pericardial access to
the vena cava. RESULTS: In the first case cold ischemia time to the
liver was 5 h; the total operating time was 19 h, and patient is still
alive at 23 months after surgery. In the second case cold ischemia
time to the liver was 2 h; the total operating time was 9 h, and patient
is alive at 2 months after surgery. CONCLUSION: These two cases
are the paradigm of the possibility of performing extreme salvage
procedures after the failure of more conventional treatments allowing
improvement in survival and quality of life in a controversial clinical
scenario.
44 THE USE OF THE PROMETHEUS SYSTEM IN THE
TREATMENT OF ACUTE LIVER FAILURE IN THE COURSE
OF AMANITA PHALLOIDES INTOXICATION
Krawczyk M1, Skwarek A1, Grodzicki M1, Nyckowski P1,
Zieniewicz K1, Najnigier B1, Patkowski W1, Smoter P1, Paczek L2,
(1) Department of General, Transplant and Liver Surgery;
(2) Departmet of Immunology, Transplantation Medicine and
Internal Disease, Medical University, Warsaw, Poland
INTRODUCTION AND AIM: The authors present outcomes in
patients with acute liver failure in the course of Amanita phalloides
intoxication treated with the Prometheus system. PATIENTS AND
METHODS: Between September 2003 and November 2004 frac-
tionated plasma separation and adsorption (FPSA) procedures
were performed in 4 patients. The patients qualified for the proce-
dure according to King’s College Hospital criteria. The procedures
were performed with a Prometheus 4008H Fresenius Medical Care
unit. The patient’s general condition was assessed on the basis of
UNOS, Child, GCS and 4-grade encephalopathy classifications. The
following the liver function tests (LFTs) were determined before
and after the procedure. RESULTS: 11 procedures were performed.
Mean duration of procedure was 6.5 h. Mean values of LFTs before
and after procedure were as follows: bilirubin (10.2 mg/dl vs 5.1 mg/
dl; p50.01), ammonia (246.4 mg/ml vs 138.2 mg/ml; p50.01), AST
(2149.5 U/L vs 878.9 U/L; p50.01), ALT (3678.6 U/L vs
1453.7 U/L; p50.01), urea (56.7 mg/dl vs 23.7 mg/dl), creatinine
(2.7 mg/dl vs 1.2 mg/dl), pH (7.28 vs 7.38). One patient did not
require OLTx. In 3 patients OLTX was performed. In one case
OLTx outcome was positive. 2 patients died after OLTx due to sep-
ticemia. CONCLUSION: The results suggest that the Prometheus
system allows for detoxication treatment of these patients, already to
qualified for urgent OLTx.
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